glp-1 drugs in development What is the pipeline for future medications for obesity? Upcoming wave of hormone-based therapies

A phylogenomic and molecular signature based approach for characterization of the phylum Spirochaetes and its major clades: proposal for a taxonomic revision of the phylum

Greater doses provided greater weight loss and caused more side effects such as upset stomach and, in rare instances, dysesthesia (2.3%4.5% of those enrolled)

The bigger picture

They are not even close to the same thing

Materials and methods Animal models In these studies, APOE-TR mice were housed in groups of up to four under standard laboratory conditions at 23 1C, 50 5% humidity, with a 12-h light/dark cycle and access to food and water ad libitum

Clinical Evidence: Research showed a 58% reduction in hair loss and a 35% increase in hair density among users of biotinoyl tripeptide-1